Literature DB >> 24704697

Highly flexible and rapidly degradable papaverine-loaded electrospun fibrous membranes for preventing vasospasm and repairing vascular tissue.

Wankun Zhu1, Shenghe Liu2, Jingwen Zhao1, Shen Liu2, Shichao Jiang2, Bin Li3, Huilin Yang3, Cunyi Fan4, Wenguo Cui5.   

Abstract

Vasospasm is a common post-operative complication after vascular anastomosis. Currently, the main treatment is a local injection of antispasmodic drugs. However, this method has a high rate of relapse and is subject to a large degree of individual variation, and repeated injections cause additional pain for patients. In this study, we developed highly flexible and rapidly degradable papaverine-loaded electrospun fibrous membranes to be wrapped around vascular suturing to prevent vasospasm. Poly-l-lactic acid/polyethylene glycol (PLLA/PEG) electrospun fibers containing papaverine maintained a high degree of flexibility and could withstand any folding, and are therefore suitable for wrapping vascular suturing. A rapid release of papaverine, between 2 and 7 days, was achieved by adjusting the proportions of PEG and PLLA. PLLA electrospun fibers containing 40% PEG (PLLA-40%) could control drug release and polymer degradation most effectively during the first 2 weeks post-operation. Testing using an in vivo rabbit model showed that PLLA-40% fibrous membranes produced significant antispasmodic effect without observable inflammation or hyperplasia, and the fibrous membranes were ideally biodegradable, with no impact on regional blood flow, pressure, vessel diameter or surrounding tissue hyperplasia. Therefore, papaverine-loaded electrospun fibrous membranes show the potential to greatly reduce post-operative vasospasm and maintain regular vascular morphology during antispasmodic therapy.
Copyright © 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Electrospun fibers; Papaverine; Rapid degradation; Vascular; Vasospasm

Mesh:

Substances:

Year:  2014        PMID: 24704697     DOI: 10.1016/j.actbio.2014.03.023

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  3 in total

1.  Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway.

Authors:  Yalong Dang; Yalin Mu; Kun Wang; Ke Xu; Jing Yang; Yu Zhu; Bin Luo
Journal:  Drug Des Devel Ther       Date:  2016-02-26       Impact factor: 4.162

2.  The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson's disease mouse models.

Authors:  Yu-Young Lee; Jin-Sun Park; Yea-Hyun Leem; Jung-Eun Park; Do-Yeon Kim; Youn-Hee Choi; Eun-Mi Park; Jihee Lee Kang; Hee-Sun Kim
Journal:  J Neuroinflammation       Date:  2019-12-02       Impact factor: 8.322

3.  Regulated extravascular microenvironment via reversible thermosensitive hydrogel for inhibiting calcium influx and vasospasm.

Authors:  Binfan Zhao; Yaping Zhuang; Zhimo Liu; Jiayi Mao; Shutong Qian; Qiuyu Zhao; Bolun Lu; Xiyuan Mao; Liucheng Zhang; Yuguang Zhang; Wenguo Cui; Xiaoming Sun
Journal:  Bioact Mater       Date:  2022-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.